Inter Pharma PCL (BKK:IP)
Thailand · Delayed Price · Currency is THB 3.740
-0.060 (-1.58%)
Sep 17, 2025, 4:36 PM ICT
Inter Pharma PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Operating Revenue | 2,034 | 1,897 | 1,781 | 1,523 | 908.63 | 442.1 | Upgrade |
Other Revenue | 17.21 | 14.62 | 17.54 | 11.12 | 12.35 | 4.84 | Upgrade |
| 2,051 | 1,912 | 1,799 | 1,534 | 920.98 | 446.94 | Upgrade | |
Revenue Growth (YoY) | 13.36% | 6.29% | 17.23% | 66.61% | 106.07% | 18.90% | Upgrade |
Cost of Revenue | 1,239 | 1,187 | 1,122 | 905.42 | 507.85 | 182.77 | Upgrade |
Gross Profit | 812.01 | 724.64 | 676.98 | 629.03 | 413.14 | 264.17 | Upgrade |
Selling, General & Admin | 687.1 | 649.1 | 567.58 | 458.23 | 267.36 | 187.22 | Upgrade |
Operating Expenses | 687.1 | 649.1 | 567.58 | 458.23 | 267.36 | 187.22 | Upgrade |
Operating Income | 124.91 | 75.53 | 109.4 | 170.8 | 145.77 | 76.95 | Upgrade |
Interest Expense | -19.76 | -19.85 | -25.76 | -23.34 | -8.01 | -1.14 | Upgrade |
Earnings From Equity Investments | -0.94 | -1.59 | -2.27 | -0.77 | -0.08 | -0.16 | Upgrade |
EBT Excluding Unusual Items | 104.21 | 54.1 | 81.37 | 146.69 | 137.68 | 75.65 | Upgrade |
Pretax Income | 104.21 | 54.1 | 81.37 | 146.69 | 137.68 | 75.65 | Upgrade |
Income Tax Expense | 22.13 | 16.42 | 22.47 | 19.41 | 27.2 | 16.39 | Upgrade |
Earnings From Continuing Operations | 82.08 | 37.68 | 58.9 | 127.29 | 110.48 | 59.26 | Upgrade |
Minority Interest in Earnings | -9.86 | -0.4 | -8.11 | -8.4 | -5.27 | -6.72 | Upgrade |
Net Income | 72.22 | 37.28 | 50.79 | 118.88 | 105.22 | 52.54 | Upgrade |
Net Income to Common | 72.22 | 37.28 | 50.79 | 118.88 | 105.22 | 52.54 | Upgrade |
Net Income Growth | 254.12% | -26.60% | -57.28% | 12.99% | 100.27% | 20.85% | Upgrade |
Shares Outstanding (Basic) | 605 | 605 | 605 | 532 | 475 | 470 | Upgrade |
Shares Outstanding (Diluted) | 605 | 605 | 605 | 532 | 475 | 470 | Upgrade |
Shares Change (YoY) | - | - | 13.78% | 11.97% | 1.05% | 31.92% | Upgrade |
EPS (Basic) | 0.12 | 0.06 | 0.08 | 0.22 | 0.22 | 0.11 | Upgrade |
EPS (Diluted) | 0.12 | 0.06 | 0.08 | 0.22 | 0.22 | 0.11 | Upgrade |
EPS Growth | 254.13% | -26.60% | -62.45% | 0.91% | 98.19% | -8.39% | Upgrade |
Free Cash Flow | 19.23 | -59.59 | 14.96 | 115.72 | -265.73 | -21.27 | Upgrade |
Free Cash Flow Per Share | 0.03 | -0.10 | 0.03 | 0.22 | -0.56 | -0.04 | Upgrade |
Dividend Per Share | - | - | 0.021 | 0.111 | - | 0.010 | Upgrade |
Dividend Growth | - | - | -80.69% | - | - | -87.33% | Upgrade |
Gross Margin | 39.59% | 37.90% | 37.64% | 40.99% | 44.86% | 59.11% | Upgrade |
Operating Margin | 6.09% | 3.95% | 6.08% | 11.13% | 15.83% | 17.22% | Upgrade |
Profit Margin | 3.52% | 1.95% | 2.82% | 7.75% | 11.42% | 11.76% | Upgrade |
Free Cash Flow Margin | 0.94% | -3.12% | 0.83% | 7.54% | -28.85% | -4.76% | Upgrade |
EBITDA | 173.07 | 138.35 | 167.66 | 208.7 | 170.85 | 82.14 | Upgrade |
EBITDA Margin | 8.44% | 7.24% | 9.32% | 13.60% | 18.55% | 18.38% | Upgrade |
D&A For EBITDA | 48.16 | 62.82 | 58.25 | 37.9 | 25.08 | 5.19 | Upgrade |
EBIT | 124.91 | 75.53 | 109.4 | 170.8 | 145.77 | 76.95 | Upgrade |
EBIT Margin | 6.09% | 3.95% | 6.08% | 11.13% | 15.83% | 17.22% | Upgrade |
Effective Tax Rate | 21.24% | 30.35% | 27.61% | 13.23% | 19.75% | 21.67% | Upgrade |
Revenue as Reported | 2,051 | 1,912 | 1,799 | 1,534 | 920.98 | 446.94 | Upgrade |
Advertising Expenses | - | 93.14 | 70.61 | 31.91 | 41.13 | 36.63 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.